ABUS vs VRTX: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Vertex Pharmaceuticals Inc in 2026
ABUS
Arbutus Biopharma Corp
—
VRTX
Vertex Pharmaceuticals Inc
$486.63
Key Metrics Comparison
| Metric | ABUS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $882.99M | $106.87B | VRTX |
| P/E Ratio | 5.39 | 29.67 | ABUS |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABUS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or VRTX a better investment?
Comparing ABUS and VRTX: Arbutus Biopharma Corp has a market cap of $882.99M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and VRTX?
ABUS (Arbutus Biopharma Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or VRTX?
Based on P/E ratios, ABUS trades at a lower multiple (5.4x vs 29.7x).
Which is growing faster: ABUS or VRTX?
Both ABUS and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABUS or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABUS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $882.99M for ABUS.
Should I buy ABUS or VRTX in 2026?
Both ABUS and VRTX have investment merit. ABUS trades at $N/A while VRTX trades at $486.63. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and VRTX stock?
Key differences: Market Cap ($882.99M vs $106.87B), P/E Ratio (5.4x vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABUS or VRTX in 2026?
The choice between ABUS and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABUS and VRTX?
ABUS (Arbutus Biopharma Corp) has a market cap of $882.99M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.